Safety Study of Stemchymal® in Acute Liver Failure

Exclusion Criteria

• •1. Subjects who had been enrolled in any other cell therapy within six months.
• •2. Females with a positive pregnancy test result.
• •3. Subjects have contraindication for liver transplantation.
• •4. Subjects with psychiatric illnesses.
• •5. Subjects who are diagnosed as active tuberculosis (TB).
• •6. Subjects with immunological disorders (e.g. autoimmune hepatitis) or using immunosuppressive drugs (e.g. steroid for immunosuppression) within six months prior to screening visit.
• •7. Subjects with unstable illnesses or contraindication for this clinical trial according to investigator's judgment.